GBLX GB Sciences Inc

GB Sciences, Inc. engages in the biopharmaceutical research and development of cannabis plant into medicines, therapies, and treatments. It intends to identify and develop cannabis-based therapies that target specific diseases or medical conditions. The company was founded on April 4, 2001 and is headquartered in Las Vegas, NV.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.02    OTCQB
As of 03/23/2023     OTCMarkets

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  12/30/2003
Outstanding shares:  379,205,894
Average volume:  128,080
Market cap:   $7,015,309
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%